obtained from basic research on model organisms into clinical application. Duration: 2024 – 2029 Funded by: FWF – Clusters of Excellence, Medical University of Graz Project partners/a> Environmental modulation [...] novel therapeutic strategies mimicking beneficial environmental stimulation. Duration: 2022 – 2026 Funded by: FWF Project partners: Akos Heinemann, Division of Pharmacology; Christoph Magnes, Joanneum Research; [...] d how changes in the expression of these genes affect aggressive behavior. Duration: 2017 – 2025 Funded by: FWF, Medical University of Graz Project partners: Karl Kashofer, Diagnostik- und Forschungsinstitut
that enable highly precise manipulation of TRPC signaling in human tissues. Duration: 2020-10/2024 Funded by: FWF P33263 Project partners: Dirk Trauner, NYU, USA; Thomas Stockner, Medical University of Vienna [...] the therapeutic relevance of the regulatory phospholipidome of TRPV6 channels. Duration: 2024-2027 Funded by: FWF PAT 9543223 Project partners: Alexander Sobolevsky, Columbia University, NY, USA; Thomas [...] specific target tissues, will be established to enable highly effective, light-mediated intervention. Funding application pending at FWF – PI Sanja Curcic Division of Biophysics Univ.-Prof. Mag. Dr. Klaus Groschner
(ChIP-MS, BioID) and transcriptomics to define starvation-specific p53 target genes. Duration: 2017-2021 Funded by: FWF, Stadt Graz, Med Uni Graz, Lanyar Stiftung, EMBO, Horizon 2020 (EPIC-XS) Project partners: [...] identifying new therapeutic targets for the control of obesity-associated diseases. Duration: 2017-2021 Funded by: FWF, PhD faculty MolMed Project partners: Charité Berlin (Schupp), Deutsches Institut für Er [...] increases the efficiency of standard therapy in a p53-dependent manner in HCC. Duration: 2016-2023 Funded by: FWF, ÖNB, MEFO Graz, Horizon 2020 (EPIC-XS) Project partners: Max Planck Institut Dresden (Huch)
all forms of PH and how these cells regulate vascular remodelling processes. Duration: 2021-2025 Funding body: FWF (KLI 844-B) Project partners: Paul Vesely, Bernhard Reiter, Olaya Esparta Gonzalez (Otto [...] may control the transition to a chronic inflammatory environment found in PH. Duration: 2021-2025 Funding body: Medical University of Graz Project partners: Olaya Esparta Gonzalez, Paul Vesely, Grazyna [...] l specific fingerprint and discriminates between different COPD phenotypes. Duration: 2021-2025 Funding body: FWF DOC 129, RespImmun Project partners: Ayu Hutami Syarif, Bernhard Reiter, Slaven Crnkovic
, administrative staff, occupational therapists, physical therapists and educators. Third-party funding is also provided by Steirische Kinderkrebshilfe (Styrian childhood cancer organization). Head of
For these groups of people, an additional budget is available for so-called top-ups (higher monthly funds for a stay abroad) or inclusion support.
transporters that can specifically be targeted to inhibit T cell pathogenicity. Duration: ongoing Funded by: Med Uni Graz, Worldwide Cancer Research Project partners: Julia Kargl, Otto Loewi Research Center [...] mediators as biomarkers of disease activity in such life-threatening conditions. Duration: ongoing Funded by: Med Uni Graz, ÖMSFG, Kulturamt der Stadt Graz Project partners: Michael Khalil, Division of General
invitation to a job shadowing, workshop or other training format at Med Uni Graz. Opportunities for a funded staff mobility for teaching or training Europe: Erasmus+ program countries EU member states including [...] University of Missouri – Kansas City Application Depending on the mobility program, the application for funding and financing will be handled by your home institution or Med Uni Graz. Please contact the International
university and to contribute to its external profile, attracting better competitive third-party funding and tapping potential synergies beyond the research center. Members Researchers Dohr Gottfried Gauster
into teaching. They include instructors from the social insurance system (Austrian Health Insurance Fund, ÖGK), occupational medicine, medical technology, patient safety, school physician, entrepreneurship
